Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting

Serine Hydroxymethyltransferase 1 and 2 (SHMT1/2), as key enzymes in folate metabolism, regulate diverse physiological processes through one-carbon metabolism, including nucleotide biosynthesis, methylation reactions, and redox homeostasis. As a form of metabolic reprogramming, dysregulated SHMT-mediated one-carbon metabolism has been increasingly reported in various human cancers and liver metabolic diseases. Therefore, a concise review of its regulatory roles and disease-associated functions is necessary to clarify its biological and translational significance. This review summarizes the molecular functions of SHMT1/2, with particular emphasis on their central roles in the folate-methionine cycle and serine-glycine metabolic pathway. Beyond their canonical enzymatic activities, SHMT1/2 also exhibit critical non-enzymatic functions. Their activity is tightly regulated by transcription factors and post-translational modifications. SHMT1/2 play significant roles in multiple pathological conditions and are implicated in the initiation and progression of various cancers, such as ovarian, lung, liver, gastric, colorectal, and renal carcinomas. Moreover, SHMT-mediated one-carbon metabolism critically influences liver diseases (e.g., non-alcoholic fatty liver disease, steatohepatitis), inflammatory disorders (e.g., skin inflammation, osteoarthritis), and neurological diseases (e.g., schizophrenia, hypomyelinating leukodystrophy, stroke). Finally, this review discusses the clinical translational potential of SHMT inhibitors in cancer-targeted therapies, offering a theoretical basis for expanding the therapeutic applications of SHMT1/2 in diseases associated with dysregulated one-carbon metabolism. SHMT1/2 regulate diseases associated with dysregulated one-carbon metabolism through both their enzymatic and non-enzymatic functions. Particularly in cancer, they function as either oncogenes or tumor suppressors in a context-dependent manner, holding significant potential as diagnostic, prognostic, and therapeutic targets.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-04-21
DOI
https://doi.org/10.1186/s12967-026-08044-x
Primary Topic
Amino Acid Enzymes and Metabolism
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting

Xueqing Zhang, Jia-Ying Li
Journal of Translational Medicine
Amino Acid Enzymes and Metabolism
article

Serine Hydroxymethyltransferase (SHMT) in biology and disease: molecular mechanisms and therapeutic targeting

Xueqing Zhang, Jia-Ying Li
article en

Abstract

Serine Hydroxymethyltransferase 1 and 2 (SHMT1/2), as key enzymes in folate metabolism, regulate diverse physiological processes through one-carbon metabolism, including nucleotide biosynthesis, methylation reactions, and redox homeostasis. As a form of metabolic reprogramming, dysregulated SHMT-mediated one-carbon metabolism has been increasingly reported in various human cancers and liver metabolic diseases. Therefore, a concise review of its regulatory roles and disease-associated functions is necessary to clarify its biological and translational significance. This review summarizes the molecular functions of SHMT1/2, with particular emphasis on their central roles in the folate-methionine cycle and serine-glycine metabolic pathway. Beyond their canonical enzymatic activities, SHMT1/2 also exhibit critical non-enzymatic functions. Their activity is tightly regulated by transcription factors and post-translational modifications. SHMT1/2 play significant roles in multiple pathological conditions and are implicated in the initiation and progression of various cancers, such as ovarian, lung, liver, gastric, colorectal, and renal carcinomas. Moreover, SHMT-mediated one-carbon metabolism critically influences liver diseases (e.g., non-alcoholic fatty liver disease, steatohepatitis), inflammatory disorders (e.g., skin inflammation, osteoarthritis), and neurological diseases (e.g., schizophrenia, hypomyelinating leukodystrophy, stroke). Finally, this review discusses the clinical translational potential of SHMT inhibitors in cancer-targeted therapies, offering a theoretical basis for expanding the therapeutic applications of SHMT1/2 in diseases associated with dysregulated one-carbon metabolism. SHMT1/2 regulate diseases associated with dysregulated one-carbon metabolism through both their enzymatic and non-enzymatic functions. Particularly in cancer, they function as either oncogenes or tumor suppressors in a context-dependent manner, holding significant potential as diagnostic, prognostic, and therapeutic targets.

Journal of Translational MedicineVol. 24(1)
Soochow University (CN)
Innovative Research Group Project of the National Natural Science Foundation of China
Openalex Percentile: Top 20%
Amino Acid Enzymes and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.